本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

1药网

8.42
+0.06160.74%
盘后8.36-0.0600-0.71%16:30 EDT
成交量:5,287.00
成交额:4.33万
市值:7,297.98万
市盈率:-8.16
高:8.42
开:8.31
低:8.07
收:8.36
数据加载中...
2025/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

SEC问询函

Form CORRESP - Correspondence
2023/07/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/27

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/19

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/19

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/20

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]